What is Rapport Therapeutics, Inc.'s net change in cash?

Rapport Therapeutics, Inc. (RAPP) reported net change in cash of $25.41M in Q1 2026.

How has Rapport Therapeutics, Inc.'s net change in cash changed year-over-year?

Rapport Therapeutics, Inc.'s net change in cash increased by 3080.4% year-over-year, from $799K to $25.41M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Rapport Therapeutics, Inc. RAPP Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

Supernus PharmaceuticalsSUPN

$56.42M+21.3%

Xenon PharmaceuticalsXENE

$346.7M+1,431%

Praxis Precision Medicines, Inc.PRAX

$179M+459%

BiohavenBHVN

$44.33M+30,054%

Septerna, Inc.SEPN

-$49.12M-74.5%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.86B+309%

Enterprise value$1.79B+352%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s net change in cash?: Rapport Therapeutics, Inc. (RAPP) reported net change in cash of $25.41M in Q1 2026.
How has Rapport Therapeutics, Inc.'s net change in cash changed year-over-year?: Rapport Therapeutics, Inc.'s net change in cash increased by 3080.4% year-over-year, from $799K to $25.41M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.